This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by French, M. T. Articles by Durell, J. Search for Related Content PubMed PubMed Citation Articles by French, M. T. Articles by Durell, J. Pubmed/NCBI databases Medline Plus Health Information Assisted Living Drug Abuse Social Bookmarking                         What's this?

Benefit-Cost Analysis of Residential and Outpatient Addiction Treatment in the State of Washington

University of Miami, Miami

Helena J. Salomé

University of Miami, Miami

Antoinette Krupski

State of Washington, Olympia

James R. Mckay

University of Pennsylvania, and DeltraMetrics, Philadelphia

Dennis M. Donovan

University of Washington, Seattle

A. Thomas Mclellan

University of Pennsylvania, and DeltraMetrics, Philadelphia

Jack Durell

DeltaMetrics, Philadelphia

A benefit-cost analysis of full continuum (FC) and partial continuum (PC) care was conducted on a sample of substance abusers from the State of Washington. Economic benefits were derived from client self-reported information at treatment entry and at 9 months postadmission using an augmented version of the Addiction Severity Index (ASI). Average (i.e., per client) economic benefits of treatment from baseline to follow-up for both FC and PC were statistically significant for most variables and in the aggregate. The overall difference in average economic benefit between FC and PC was positive ($8,053) and statistically significant, favoring FC over PC. The average cost of treatment amounted to $2,530 for FC and $1,138 for PC (p < .01). Average net benefits were estimated to be $17,833 (9.70) for FC and $11,173 (23.33) for PC, with values showing statistical significance (p < .05). Results strongly indicate that both treatment options generated positive and significant net benefits to society.

Evaluation Review, Vol. 24, No. 6, 609-634 (2000)
DOI: 10.1177/0193841X0002400603


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				I. Popovici, M. T. French, and J. R. McKay Economic Evaluation of Continuing Care Interventions in the Treatment of Substance Abuse: Recommendations for Future Research Eval Rev, December 1, 2008; 32(6): 547 - 568. [Abstract] [PDF]

				B. P. SMYTH, J. BARRY, A. LANE, M. COTTER, M. O'NEILL, C. QUINN, and E. KEENAN In-patient treatment of opiate dependence: medium-term follow-up outcomes The British Journal of Psychiatry, October 1, 2005; 187(4): 360 - 365. [Abstract] [Full Text] [PDF]

				J. R. Hepburn Recidivism Among Drug Offenders Following Exposure to Treatment Criminal Justice Policy Review, June 1, 2005; 16(2): 237 - 259. [Abstract] [PDF]

				E. M. Howell, R. B. Greifinger, and A. S. Sommers What Is Known About the Cost-Effectiveness of Health Services for Returning Prisoners? Journal of Correctional Health Care, April 1, 2004; 10(3): 399 - 436. [Abstract] [PDF]

				M. T. French, M. C. Roebuck, M. L. Dennis, S. H. Godley, H. A. Liddle, and F. M. Tims Outpatient Marijuana Treatment for Adolescents: Economic Evaluation of a Multisite Field Experiment Eval Rev, August 1, 2003; 27(4): 421 - 459. [Abstract] [PDF]